Press Release
The AGEs Society will hold a "Practical Lecture on Disease Consultation" in Eunpyeong on the 25th.
2024.09.09 16:04- 작성자 관리자
- 조회 220
[DailyPharm Reporter: Hye-Kyoung Kang] The AGEs Society (CEO Myoung-Gyu Park) will be holding a practical lecture titled "Understanding the Concept of Glycotoxins and Disease Consultation" at the Eunpyeong District Pharmaceutical Association on the 25th.
The lecture will cover two main topics: "Consulting in Pharmacies from a Glycotoxin Perspective" by academic representative pharmacist Ah-Reum Kim, and "The Causes of Modern Diseases: Why Glycotoxins Are Key and the Technology to Reduce Them" by CEO Myoung-Gyu Park. The session is scheduled to run from 4:00 PM to 7:10 PM.
Pharmacists attending the event will receive a set of materials, including AGE Probiotic V, the Dryness Solution 3-set, and lecture handouts.
The AGEs Society explained, "MetaCen Therapeutics is committed to promoting the operation of consultation-focused pharmacies and enhancing public health through research on glycotoxin (AGEs) management technologies and new drug development. We are actively pursuing the development of new drugs through research on technology that effectively breaks down, expels, and detoxifies glycotoxins, along with the creation of new substances."
Source: [DailyPharm](http://www.dailypharm.com)
The lecture will cover two main topics: "Consulting in Pharmacies from a Glycotoxin Perspective" by academic representative pharmacist Ah-Reum Kim, and "The Causes of Modern Diseases: Why Glycotoxins Are Key and the Technology to Reduce Them" by CEO Myoung-Gyu Park. The session is scheduled to run from 4:00 PM to 7:10 PM.
Pharmacists attending the event will receive a set of materials, including AGE Probiotic V, the Dryness Solution 3-set, and lecture handouts.
The AGEs Society explained, "MetaCen Therapeutics is committed to promoting the operation of consultation-focused pharmacies and enhancing public health through research on glycotoxin (AGEs) management technologies and new drug development. We are actively pursuing the development of new drugs through research on technology that effectively breaks down, expels, and detoxifies glycotoxins, along with the creation of new substances."
Source: [DailyPharm](http://www.dailypharm.com)